Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Vale

Showing results (381-390 of 403) with videos related to

Pageof 41
Sort By:
Experimental Parasitology|March 21, 2024
Treatment using vanillin-derived synthetic molecules incorporated into polymeric micelles is effective against infection caused by Leishmania amazonensis speciesIsabela A G Pereira, Camila S Freitas, Raquel S B Câmara, et al.
Cytokine|February 19, 2024
New synthetic molecules incorporated into polymeric micelles used for treatment against visceral leishmaniasisCamila S Freitas, Isabela A G Pereira, Daniela P Lage, et al.
Parasitology Research|October 19, 2021
ChimLeish, a new recombinant chimeric protein evaluated as a diagnostic and prognostic marker for visceral leishmaniasis and human immunodeficiency virus coinfectionNathalia C Galvani, Amanda S Machado, Daniela P Lage, et al.
Parasitology|November 28, 2024
Preclinical evaluation of immunogenicity and protective efficacy of a recombinant chimeric protein vaccine against visceral leishmaniasisDaniela P Lage, Danniele L Vale, Fabiana A G Maia, et al.
Microbial Pathogenesis|December 9, 2021
Sensitive and specific serodiagnosis of tegumentary leishmaniasis using a new chimeric protein based on specific B-cell epitopes of Leishmania antigenic proteinsNathalia C Galvani, Amanda S Machado, Daniela P Lage, et al.
Microbial Pathogenesis|May 5, 2022
Evaluation from a B-cell epitope-based chimeric protein for the serodiagnosis of tegumentary and visceral leishmaniasisDanniele L Vale, Amanda S Machado, Fernanda F Ramos, et al.
Acta Tropica|September 19, 2021
Potential of recombinant LiHyQ, a novel Leishmania infantum protein, for the diagnosis of canine visceral leishmaniasis and as a diagnostic and prognostic marker for human leishmaniasis and human immunodeficiency virus co-infection: A preliminary studyThaís T O Santos, Fernanda F Ramos, Isabela A P Gonçalves, et al.
Cellular Immunology|April 8, 2025
A new chimeric protein composed by T-cell epitopes from peroxidoxin and pyridoxal kinase proteins is protective against visceral leishmaniasisDaniela P Lage, Danniele L Vale, Marcela G P Silva, et al.
Diagnostic Microbiology and Infectious Disease|December 5, 2024
Urine and serum-based ELISA using a recombinant protein and synthetic peptide for the diagnosis of tegumentary leishmaniasisCamila S Freitas, Raquel S B Câmara, Daniela P Lage, et al.
Viruses|September 28, 2023
B-Cell Epitopes-Based Chimeric Protein from SARS-CoV-2 N and S Proteins Is Recognized by Specific Antibodies in Serum and Urine Samples from PatientsFernanda F Ramos, Isabela A G Pereira, Mariana M Cardoso, et al.
Pageof 41

Showing results (381-390 of 403) with videos related to

Sort By:
Pageof 41
Experimental Parasitology|March 21, 2024
Treatment using vanillin-derived synthetic molecules incorporated into polymeric micelles is effective against infection caused by Leishmania amazonensis speciesIsabela A G Pereira, Camila S Freitas, Raquel S B Câmara, et al.
Cytokine|February 19, 2024
New synthetic molecules incorporated into polymeric micelles used for treatment against visceral leishmaniasisCamila S Freitas, Isabela A G Pereira, Daniela P Lage, et al.
Parasitology Research|October 19, 2021
ChimLeish, a new recombinant chimeric protein evaluated as a diagnostic and prognostic marker for visceral leishmaniasis and human immunodeficiency virus coinfectionNathalia C Galvani, Amanda S Machado, Daniela P Lage, et al.
Parasitology|November 28, 2024
Preclinical evaluation of immunogenicity and protective efficacy of a recombinant chimeric protein vaccine against visceral leishmaniasisDaniela P Lage, Danniele L Vale, Fabiana A G Maia, et al.
Microbial Pathogenesis|December 9, 2021
Sensitive and specific serodiagnosis of tegumentary leishmaniasis using a new chimeric protein based on specific B-cell epitopes of Leishmania antigenic proteinsNathalia C Galvani, Amanda S Machado, Daniela P Lage, et al.
Microbial Pathogenesis|May 5, 2022
Evaluation from a B-cell epitope-based chimeric protein for the serodiagnosis of tegumentary and visceral leishmaniasisDanniele L Vale, Amanda S Machado, Fernanda F Ramos, et al.
Acta Tropica|September 19, 2021
Potential of recombinant LiHyQ, a novel Leishmania infantum protein, for the diagnosis of canine visceral leishmaniasis and as a diagnostic and prognostic marker for human leishmaniasis and human immunodeficiency virus co-infection: A preliminary studyThaís T O Santos, Fernanda F Ramos, Isabela A P Gonçalves, et al.
Cellular Immunology|April 8, 2025
A new chimeric protein composed by T-cell epitopes from peroxidoxin and pyridoxal kinase proteins is protective against visceral leishmaniasisDaniela P Lage, Danniele L Vale, Marcela G P Silva, et al.
Diagnostic Microbiology and Infectious Disease|December 5, 2024
Urine and serum-based ELISA using a recombinant protein and synthetic peptide for the diagnosis of tegumentary leishmaniasisCamila S Freitas, Raquel S B Câmara, Daniela P Lage, et al.
Viruses|September 28, 2023
B-Cell Epitopes-Based Chimeric Protein from SARS-CoV-2 N and S Proteins Is Recognized by Specific Antibodies in Serum and Urine Samples from PatientsFernanda F Ramos, Isabela A G Pereira, Mariana M Cardoso, et al.
Pageof 41